A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/1999
08/19/1999	CA2320424A1 Human transport-associated molecules
08/19/1999	CA2320383A1 Hiv chemokines
08/19/1999	CA2320226A1 Methods and compositions for modulating leptin activity
08/19/1999	CA2320223A1 Pneumococcal and meningococcal vaccines formulated with interleukin-12
08/19/1999	CA2320104A1 Method for the prevention and treatment of a type i hypersensitivity disorder
08/19/1999	CA2320042A1 Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
08/19/1999	CA2320041A1 Vaccines comprising interleukin-12 and herpes simplex viral antigen
08/19/1999	CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999	CA2319688A1 Specific antibodies against mammary tumor-associated mucin, method for production and use
08/19/1999	CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/19/1999	CA2318068A1 Podocalyxin like sialomucins having selectin ligand activity
08/19/1999	CA2309705A1 Serological diagnosis of chagas' disease
08/18/1999	EP0935664A2 New systems for regulating genetic expression
08/18/1999	EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists
08/18/1999	EP0935660A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
08/18/1999	EP0935659A1 Compositions and methods for treating intracellular diseases
08/18/1999	EP0935653A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
08/18/1999	EP0935612A1 Precursors of catalytic antibodies
08/18/1999	EP0935470A1 Method for treating allergic lung disease
08/18/1999	EP0935458A1 Compositions containing at least one nucleic acid
08/18/1999	EP0703925B1 Production of antibody fragments
08/18/1999	EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
08/18/1999	CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium
08/18/1999	CN1226174A Use of proteinase inhibitors for prevention or reduction of bone resorption
08/18/1999	CN1226173A Chitosan induced immunopotentiation
08/18/1999	CN1226172A Method and compositions useful for inhibiting angiogenesis
08/18/1999	CN1225945A DNA encoding neospora dihydrofolate reductase-thymidylate synthase
08/18/1999	CN1225839A Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction
08/17/1999	US5939598 Method of making transgenic mice lacking endogenous heavy chains
08/17/1999	US5939540 Platelet secretory transport protein
08/17/1999	US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/17/1999	US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds
08/17/1999	US5939297 Hybrid protein
08/17/1999	US5939290 Modified sialyl Lewisx compounds
08/17/1999	US5939283 Nucleotide sequences coding a protein that activates allergic responses
08/17/1999	US5939277 Detection and treatment of breast and gynecological cancer
08/17/1999	US5939271 Recombinant nucleic acid molecule coding for polypeptide which has cell and neuron chemotactic functions; diagnosis, gene therapy, immunogens
08/17/1999	US5939075 Mutants of Brucella melitensis
08/17/1999	US5939074 Polypeptides; useful for prodcution of vaccine against hiv infection and diagnosis
08/17/1999	US5939073 Fish pancreatic disease virus
08/17/1999	US5939070 Hybrid botulinal neurotoxins
08/17/1999	US5939068 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
08/17/1999	US5939067 Gonococcal anti-idiotypic antibodies and methods and compositions using them
08/17/1999	US5939064 Bordetella bronchiseptica vaccine
08/17/1999	CA2076648C Composition for inducing humoral anergy to an immunogen
08/17/1999	CA1340712C Leukotoxin gene of pasturella haemolytica
08/12/1999	WO1999040207A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
08/12/1999	WO1999040200A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
08/12/1999	WO1999040196A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
08/12/1999	WO1999040188A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
08/12/1999	WO1999040185A1 Cytotoxic heteromeric protein combinatorial libraries
08/12/1999	WO1999040119A1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
08/12/1999	WO1999040115A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
08/12/1999	WO1999040113A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
08/12/1999	WO1999040111A1 The aiolos gene
08/12/1999	WO1999040110A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
08/12/1999	WO1999040104A1 Neokine protein and nucleic acid molecules and uses therefor
08/12/1999	WO1999039739A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
08/12/1999	WO1999039736A2 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES
08/12/1999	WO1999039735A1 Live vaccine for human immunodeficiency virus
08/12/1999	WO1999039733A1 Delivery method for recombinant raccoon poxvirus
08/12/1999	WO1999039731A1 Copolymer compositions for oral delivery
08/12/1999	WO1999039729A2 Use of heregulin as an epithelial cell growth factor
08/12/1999	WO1999039727A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999	WO1999039726A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999	WO1999039693A2 Methods and compositions for detection and diagnosis of infectious diseases
08/12/1999	WO1999039582A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
08/12/1999	WO1999031230A3 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof
08/12/1999	WO1999028344A3 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
08/12/1999	WO1999025378A9 Immunoglobulin molecules having a synthetic variable region and modified specificity
08/12/1999	WO1999024049A9 Insect cells or fractions as adjuvant for antigens
08/12/1999	WO1999022761A9 Conjugate heat shock protein-binding peptides
08/12/1999	WO1999018226A9 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
08/12/1999	WO1999009177A3 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
08/12/1999	WO1999004820A3 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
08/12/1999	WO1999002132A3 Use of submicron oil-in-water emulsions with dna vaccines
08/12/1999	DE19803453A1 Vakzine Vaccine
08/12/1999	DE19801265C1 Inhibierung von CD95-unabhängiger Apoptose bei AIDS Inhibiting CD95-independent apoptosis in AIDS
08/12/1999	CA2751655A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
08/12/1999	CA2320489A1 Live vaccine for human immunodeficiency virus
08/12/1999	CA2320470A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
08/12/1999	CA2320359A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
08/12/1999	CA2320144A1 Neokine protein and nucleic acid molecules and uses therefor
08/12/1999	CA2320098A1 Compositions and methods to inhibit formation of the c5b-9 complex of complement
08/12/1999	CA2319764A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999	CA2319448A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999	CA2319236A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
08/12/1999	CA2318857A1 Use of heregulin as an epithelial cell growth factor
08/11/1999	EP0934999A1 DNA mutagenesis by random fragmentation and reassembly
08/11/1999	EP0934421A1 DNA INTEGRATION INTO "MYCOBACTERIUM spp." GENOME BY TRANS-COMPLEMENTATION USING A SITE-SPECIFIC INTEGRATION SYSTEM
08/11/1999	EP0934416A1 Feline polynucleotide vaccine formula
08/11/1999	EP0934413A1 Placental-derived prostate growth factors
08/11/1999	EP0934412A1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF
08/11/1999	EP0934408A1 Nucleic acid encoding ds-cam proteins and products related thereto
08/11/1999	EP0934405A1 Melanoma associated peptide analogues and vaccines against melanoma
08/11/1999	EP0934340A1 Novel compounds
08/11/1999	EP0934338A1 Cellular internalization of pigr stalk and associated ligands
08/11/1999	EP0934336A1 Novel compounds
08/11/1999	EP0934335A1 Novel compounds
08/11/1999	EP0934333A1 Unique associated kaposi's sarcoma virus sequences and uses thereof

1 ... 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 ... 1823